Farber disease, also known as Farber lipogranulomatosis, is a rare inherited metabolic disorder characterized by the abnormal accumulation of lipids (fats) in various tissues of the body. This condition is caused by a deficiency of the enzyme ceramidase, which leads to the buildup of a fatty substance called ceramide.
In the International Classification of Diseases, 10th Revision (ICD-10), Farber disease is classified under the code E75.2. This code falls under the category of "Other sphingolipidosis" (E75), which encompasses a group of disorders characterized by abnormalities in the metabolism of sphingolipids.
On the other hand, in the previous version of the classification system, ICD-9, Farber disease is classified under the code 272.7. This code corresponds to the category of "Other disorders of lipoid metabolism" (272), which includes various lipid storage disorders.
It is important to note that while ICD-10 is the current coding system used by healthcare professionals, ICD-9 codes are still sometimes referenced for historical or research purposes. However, the transition to ICD-10 allows for more specific and detailed coding, providing a better understanding of the specific conditions being diagnosed and treated.
In conclusion, the ICD-10 code for Farber disease is E75.2, while the corresponding code in ICD-9 is 272.7. These codes help healthcare professionals accurately identify and classify the condition, enabling appropriate diagnosis, treatment, and research.
Author: DiseaseMaps Editorial Team
Reviewed against authoritative medical sources (NIH GARD, Orphanet, OMIM)
Last updated: 2023-07-10
Medical disclaimer:
This information does not substitute professional medical advice. Always consult your doctor before making health decisions.